India  
 
NewsR.in

Covaxin's efficacy expected to be more than 90%: Dr OP Kalra

Video Credit: ANI - Duration: 01:58s - Published
Covaxin's efficacy expected to be more than 90%: Dr OP Kalra

Covaxin's efficacy expected to be more than 90%: Dr OP Kalra

Vice-Chancellor of Pt BD Sharma University of Health Sciences, (Rohtak), OP Kalra during a press conference on November 18 said that the third phase of Covaxin will start from November 20.

OP Kalra said, "Third phase trial of Covaxin to start from 20 Nov.

200 volunteers to be administered the vaccine early to study its anti-bodies response.

There will be 2 doses; 2nd dose to be given 28 days after the first dose.

Vaccine's efficacy is expected to be more than 90%."


You Might Like


Related videos from verified sources

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C [Video]

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

The third-phase trial of Bharat Biotech's Covid-19 vaccine candidate, Covaxin will begin from November 20. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes..

Credit: HT Digital Content     Duration: 02:29Published